CVR: 16406899
Secondary names: NYCOMED DANMARK A/S, DAK LABORATORIES A/S, NYCOMED DAK A/S
Previous names: DAK-LABORATORIET A/S, NYCOMED DAK A/S, NYCOMED DANMARK A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Koki Sato. The company is owned by Takeda Pharmaceuticals International AG. The company has 209 employees. In 2025, the company reported revenue of DKK 1,102,419,000 and a net result of DKK 12,162,000 compared with DKK 261,222,000 the year before. Equity amounted to DKK 368,294,000.
The financial health of TAKEDA PHARMA A/S appears to be fluctuating, with a notable decline in profitability over the past few years. Revenue peaked at 1,939,231,000 DKK in 2021 but has since decreased to 1,102,419,000 DKK in 2025, while profit has significantly dropped from 667,744,000 DKK in 2021 to just 12,162,000 DKK in 2025. Despite a positive equity trend, increasing from 81,238,000 DKK in 2022 to 368,294,000 DKK in 2025, the company's profit margins are concerning. Positioned within the pharmaceutical wholesale industry, its recent performance raises questions about operational efficiency and market competitiveness.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er udvikling og fremstilling af samt handel med lægemidler og hermed beslægtede varer.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.1 mia. | 12.2 mio. | 581.3 mio. | 368.3 mio. | 68 | |
| 2024 | 1.1 mia. | 261.2 mio. | 582.4 mio. | 356 mio. | 68 | |
| 2023 | 1.1 mia. | 13.6 mio. | 485.8 mio. | 94.9 mio. | 70 | |
| 2022 | 910.1 mio. | 31.8 mio. | 622.3 mio. | 81.2 mio. | 180 | |
| 2021 | 1.9 mia. | 667.7 mio. | 2 mia. | 1 mia. | 174 | |
| 2020 | 1.6 mia. | 2.7 mia. | 3.8 mia. | 2.7 mia. | 179 | |
| 2019 | 1.6 mia. | 84.7 mia. | 1.5 mia. | 1.3 mia. | 177 | |
| 2018 | 1.8 mia. | 595.8 mio. | 100.9 mia. | 100.5 mia. | 197 | |
| 2017 | 1.7 mia. | -102.6 mio. | 100.4 mia. | 99.9 mia. | 305 | |
| 2016 | 1.7 mia. | 25.3 mia. | 101 mia. | 100.2 mia. | 488 |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
Screen owners and management against the Danish FSA's official PEP lists
TAKEDA PHARMA A/S has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 516,600,000 DKK.
Contact info changed: new phone: 46771111, new email: [email protected] (April 30, 2026).
Contact info changed: new phone: 46771111, new email: [email protected] (April 20, 2026).
As of April 17, 2026, Christian Ramskov has joined the board of directors of TAKEDA PHARMA A/S.
As of April 17, 2026, Koki Sato has joined the board of directors of TAKEDA PHARMA A/S.
As of April 17, 2026, Koki Sato is registered as director of TAKEDA PHARMA A/S.
As of April 16, 2026, Christian Ramskov has left the board of directors of TAKEDA PHARMA A/S.
As of April 16, 2026, Koki Sato has left the board of directors of TAKEDA PHARMA A/S.
As of April 1, 2026, Georgios Faidon Kalomoiris has stepped down as director of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2025. Revenue came to DKK 1,102,419,000, and the net result was DKK 12,162,000.
As of September 1, 2025, Georgios Faidon Kalomoiris is registered as director of TAKEDA PHARMA A/S.
As of September 1, 2025, Christian Ramskov has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of April 1, 2025, Christian Ramskov is registered as adm. dir. of TAKEDA PHARMA A/S.
As of April 1, 2025, Roland Kurney has stepped down as adm. dir. of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2024. Revenue came to DKK 1,118,710,000, and the net result was DKK 261,222,000.
As of August 28, 2024, Koki Sato has joined the board of directors of TAKEDA PHARMA A/S.
As of August 28, 2024, Vatroslav Mateljic has left the board of directors of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2023. Revenue came to DKK 1,061,206,000, and the net result was DKK 13,573,000.
As of March 31, 2023, Vatroslav Mateljic has joined the board of directors of TAKEDA PHARMA A/S.
As of March 31, 2023, Duarte Joao Lourinho Marchand has left the board of directors of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2022. Revenue came to DKK 910,058,000, and the net result was DKK 31,795,000.
As of October 1, 2021, Roland Kurney is registered as adm. dir. of TAKEDA PHARMA A/S.
As of October 1, 2021, Roland Kurney is registered as adm. dir. of TAKEDA PHARMA A/S.
As of October 1, 2021, Roland Kurney has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of September 30, 2021, Lars Patrik Mikael Forsell has stepped down as adm. dir. of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2021. Revenue came to DKK 1,939,231,000, and the net result was DKK 667,744,000.
As of May 21, 2021, Christian Ramskov has joined the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Gitte Hjelvang has joined the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Duarte Joao Lourinho Marchand has joined the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Niels Hansen has left the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Ingeborg Rossebø Borgheim has left the board of directors of TAKEDA PHARMA A/S.
As of May 21, 2021, Athinagoras Efthymios Giannoulis has left the board of directors of TAKEDA PHARMA A/S.
As of April 1, 2021, Bjarne Mejlstrup Lange has left the board of directors of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2020. Revenue came to DKK 1,569,593,000, and the net result was DKK 2,661,113,000.
TAKEDA PHARMA A/S has published its annual report for 2019. Revenue came to DKK 1,571,272,000, and the net result was DKK 84,680,112,000.
As of August 13, 2019, Jesper Lindahl has joined the board of directors of TAKEDA PHARMA A/S.
As of August 13, 2019, Marianne Hauge has left the board of directors of TAKEDA PHARMA A/S.
As of August 12, 2019, Jesper Lindahl has left the board of directors of TAKEDA PHARMA A/S.
As of February 15, 2019, is registered as an owner of TAKEDA PHARMA A/S with an ownership share of 100%.
TAKEDA PHARMA A/S has published its annual report for 2018. Revenue came to DKK 1,782,339,000, and the net result was DKK 595,839,000.
As of December 20, 2017, Athinagoras Efthymios Giannoulis has joined the board of directors of TAKEDA PHARMA A/S.
As of December 20, 2017, Ghita Astrup has left the board of directors of TAKEDA PHARMA A/S.
As of November 20, 2017, Lars Patrik Mikael Forsell is registered as adm. dir. of TAKEDA PHARMA A/S.
As of November 20, 2017, Christian Ramskov has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of October 1, 2017, Christian Ramskov is registered as adm. dir. of TAKEDA PHARMA A/S.
As of September 30, 2017, Ghita Astrup has stepped down as adm. dir. of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2017. Revenue came to DKK 1,728,098,000, and the net result was DKK -102,646,000.
As of August 16, 2017, Marianne Jacobsen has left the board of directors of TAKEDA PHARMA A/S.
As of May 11, 2017, Ingeborg Rossebø Borgheim has joined the board of directors of TAKEDA PHARMA A/S.
As of May 11, 2017, Jean Luc Delay has left the board of directors of TAKEDA PHARMA A/S.
As of November 14, 2016, Niels Hansen has joined the board of directors of TAKEDA PHARMA A/S.
As of October 31, 2016, Lisbet Rankløve has left the board of directors of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2016. Revenue came to DKK 1,682,747,000, and the net result was DKK 25,296,957,000.
As of March 9, 2016, Jean Luc Delay has joined the board of directors of TAKEDA PHARMA A/S.
As of March 9, 2016, Dennis-Oliver Lauth has left the board of directors of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2015.
As of April 9, 2015, Marianne Jacobsen has joined the board of directors of TAKEDA PHARMA A/S.
As of April 9, 2015, Bjarne Mejlstrup Lange has joined the board of directors of TAKEDA PHARMA A/S.
As of April 9, 2015, Jesper Lindahl has joined the board of directors of TAKEDA PHARMA A/S.
As of April 8, 2015, Bjarne Mejlstrup Lange has left the board of directors of TAKEDA PHARMA A/S.
As of March 31, 2015, Kirsten Betina Kjær Christensen has left the board of directors of TAKEDA PHARMA A/S.
As of March 31, 2015, Lise Bredahl Hervik Harre has left the board of directors of TAKEDA PHARMA A/S.
As of November 20, 2014, KPMG P/S has been appointed auditor of TAKEDA PHARMA A/S.
As of November 20, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2014.
As of August 31, 2014, Bjarne Mejlstrup Lange has joined the board of directors of TAKEDA PHARMA A/S.
As of August 31, 2014, Susanne Munk has left the board of directors of TAKEDA PHARMA A/S.
As of March 20, 2014, Ghita Astrup has joined the board of directors of TAKEDA PHARMA A/S.
As of March 20, 2014, Dennis-Oliver Lauth has joined the board of directors of TAKEDA PHARMA A/S.
As of March 20, 2014, Dominic Peter Moorhead has left the board of directors of TAKEDA PHARMA A/S.
As of March 20, 2014, Gilbert Wilhelm Rademacher has left the board of directors of TAKEDA PHARMA A/S.
As of January 6, 2014, Lisbet Rankløve has joined the board of directors of TAKEDA PHARMA A/S.
As of January 6, 2014, Helle Skov Wagner has left the board of directors of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S has published its annual report for 2013.
As of July 26, 2013, Susanne Munk has joined the board of directors of TAKEDA PHARMA A/S.
As of July 26, 2013, Kirsten Betina Kjær Christensen has joined the board of directors of TAKEDA PHARMA A/S.
As of July 26, 2013, Lise Bredahl Hervik Harre has joined the board of directors of TAKEDA PHARMA A/S.
As of July 26, 2013, Carsten Martini Nielsen has left the board of directors of TAKEDA PHARMA A/S.
As of July 26, 2013, Marianne Jacobsen has left the board of directors of TAKEDA PHARMA A/S.
As of June 27, 2013, Gilbert Wilhelm Rademacher has joined the board of directors of TAKEDA PHARMA A/S.
As of June 27, 2013, Satoru Noguchi has left the board of directors of TAKEDA PHARMA A/S.
On November 30, 2012, the company changed its name from NYCOMED DANMARK ApS to TAKEDA PHARMA A/S.
As of November 26, 2012, Helle Skov Wagner has joined the board of directors of TAKEDA PHARMA A/S.
As of November 26, 2012, Charles Albert Depasse has left the board of directors of TAKEDA PHARMA A/S.
As of June 28, 2012, Dominic Peter Moorhead has joined the board of directors of TAKEDA PHARMA A/S.
As of June 28, 2012, Satoru Noguchi has joined the board of directors of TAKEDA PHARMA A/S.
As of June 28, 2012, Rickard Erik Söderberg has left the board of directors of TAKEDA PHARMA A/S.
As of June 28, 2012, Runar Bjørklund has left the board of directors of TAKEDA PHARMA A/S.
As of May 22, 2012, EY Godkendt Revisionspartnerselskab has been appointed auditor of TAKEDA PHARMA A/S.
As of May 22, 2012, JUT NR. 2180 A/S has stepped down as auditor of TAKEDA PHARMA A/S.
As of October 31, 2011, Marianne Jacobsen has joined the board of directors of TAKEDA PHARMA A/S.
As of October 31, 2011, Marianne Jacobsen has left the board of directors of TAKEDA PHARMA A/S.
As of October 31, 2011, Jørgen Dahl has left the board of directors of TAKEDA PHARMA A/S.
As of August 17, 2011, JUT NR. 2180 A/S has been appointed auditor of TAKEDA PHARMA A/S.
As of August 17, 2011, EY Danmark A/S has stepped down as auditor of TAKEDA PHARMA A/S.
As of March 16, 2009, Rickard Erik Söderberg has joined the board of directors of TAKEDA PHARMA A/S.
As of March 16, 2009, Bent Sørensen Kjærsgaard has left the board of directors of TAKEDA PHARMA A/S.
As of December 7, 2007, Marianne Hauge has joined the board of directors of TAKEDA PHARMA A/S.
As of December 7, 2007, Carsten Martini Nielsen has joined the board of directors of TAKEDA PHARMA A/S.
As of December 7, 2007, Marianne Jacobsen has joined the board of directors of TAKEDA PHARMA A/S.
As of December 7, 2007, Jørgen Dahl has joined the board of directors of TAKEDA PHARMA A/S.
As of December 7, 2007, Jesper Christian Schrøder has left the board of directors of TAKEDA PHARMA A/S.
As of December 7, 2007, Conny Ditlevsen has left the board of directors of TAKEDA PHARMA A/S.
As of May 31, 2007, Bent Sørensen Kjærsgaard has joined the board of directors of TAKEDA PHARMA A/S.
As of May 31, 2007, Ghita Astrup has left the board of directors of TAKEDA PHARMA A/S.
As of February 1, 2007, Ghita Astrup is registered as adm. dir. of TAKEDA PHARMA A/S.
As of February 1, 2007, Bent Sørensen Kjærsgaard has stepped down as director of TAKEDA PHARMA A/S.
As of January 6, 2005, Thor-Björn Gunnar Conradsson has left the board of directors of TAKEDA PHARMA A/S.
As of March 10, 2004, Ghita Astrup has joined the board of directors of TAKEDA PHARMA A/S.
As of March 5, 2004, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of TAKEDA PHARMA A/S.
As of December 10, 2003, Runar Bjørklund has joined the board of directors of TAKEDA PHARMA A/S.
As of December 10, 2003, Ulf Erik Strindholm has left the board of directors of TAKEDA PHARMA A/S.
As of August 25, 2003, Ulf Erik Strindholm has joined the board of directors of TAKEDA PHARMA A/S.
As of August 25, 2003, Petter Homdrum has left the board of directors of TAKEDA PHARMA A/S.
As of May 30, 2003, Jesper Christian Schrøder has joined the board of directors of TAKEDA PHARMA A/S.
As of May 30, 2003, Carsten Martini Nielsen has joined the board of directors of TAKEDA PHARMA A/S.
As of May 30, 2003, Carsten Martini Nielsen has left the board of directors of TAKEDA PHARMA A/S.
As of May 30, 2003, Henrik Kjeldsen has left the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, EY Danmark A/S has been appointed auditor of TAKEDA PHARMA A/S.
As of March 7, 2003, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of TAKEDA PHARMA A/S.
As of March 7, 2003, DELOITTE, HASKINS & SELLS A/S has been appointed auditor of TAKEDA PHARMA A/S.
As of March 7, 2003, DELOITTE, HASKINS & SELLS A/S has stepped down as auditor of TAKEDA PHARMA A/S.
As of March 7, 2003, has stepped down as auditor of TAKEDA PHARMA A/S.
As of March 7, 2003, Thor-Björn Gunnar Conradsson has joined the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Charles Albert Depasse has joined the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Petter Homdrum has joined the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Sven Håkan Björklund has left the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Thompson Dean has left the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Reid Samuel Perper has left the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Chinh Phu Chu has left the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Harry James Wilson has left the board of directors of TAKEDA PHARMA A/S.
As of March 7, 2003, Edward Richard Roberts has left the board of directors of TAKEDA PHARMA A/S.
As of December 20, 2002, Conny Ditlevsen has joined the board of directors of TAKEDA PHARMA A/S.
As of December 20, 2002, Henrik Kjeldsen has joined the board of directors of TAKEDA PHARMA A/S.
As of December 20, 2002, Charles Albert Depasse has left the board of directors of TAKEDA PHARMA A/S.
On December 17, 2002, the company changed its name from NYCOMED DANMARK A/S to NYCOMED DANMARK ApS.
As of November 29, 2002, Sven Håkan Björklund has joined the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Thompson Dean has joined the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Reid Samuel Perper has joined the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Chinh Phu Chu has joined the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Harry James Wilson has joined the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Edward Richard Roberts has joined the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Conny Ditlevsen has left the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Henrik Kjeldsen has left the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Thor-Björn Gunnar Conradsson has left the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Petter Homdrum has left the board of directors of TAKEDA PHARMA A/S.
As of November 29, 2002, Runar Bjørklund has left the board of directors of TAKEDA PHARMA A/S.
As of September 1, 2002, Bo Thomas Dybbro has left the board of directors of TAKEDA PHARMA A/S.
As of September 1, 2002, Carsten Martini Nielsen has left the board of directors of TAKEDA PHARMA A/S.
As of September 1, 2000, Petter Homdrum has joined the board of directors of TAKEDA PHARMA A/S.
As of September 1, 2000, Petter Homdrum has left the board of directors of TAKEDA PHARMA A/S.
As of May 31, 2000, Thor-Björn Gunnar Conradsson has joined the board of directors of TAKEDA PHARMA A/S.
As of May 31, 2000, Charles Albert Depasse has joined the board of directors of TAKEDA PHARMA A/S.
As of May 31, 2000, Leonard Ferdinand Gerard Detz has left the board of directors of TAKEDA PHARMA A/S.
As of May 31, 2000, Britt Wolden has left the board of directors of TAKEDA PHARMA A/S.
As of May 31, 1999, has been appointed auditor of TAKEDA PHARMA A/S.
As of May 31, 1999, CJ Partnership I/S has stepped down as auditor of TAKEDA PHARMA A/S.
As of March 24, 1999, Bo Thomas Dybbro has joined the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Conny Ditlevsen has joined the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Carsten Martini Nielsen has joined the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Henrik Kjeldsen has joined the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Carsten Martini Nielsen has left the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Birthe Gudrun Eriksen has left the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Helle Kit Knudsen has left the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1999, Henrik Kjeldsen has left the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Leonard Ferdinand Gerard Detz has joined the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Petter Homdrum has joined the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Runar Bjørklund has joined the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Britt Wolden has joined the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Georg Dedichen has left the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Olav Land has left the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Trond Vegard Jacobsen has left the board of directors of TAKEDA PHARMA A/S.
As of February 24, 1999, Helge Lund has left the board of directors of TAKEDA PHARMA A/S.
As of September 1, 1998, Birthe Gudrun Eriksen has joined the board of directors of TAKEDA PHARMA A/S.
As of September 1, 1998, Birthe Gudrun Eriksen has left the board of directors of TAKEDA PHARMA A/S.
As of September 1, 1998, Ole Nielsen has left the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1998, Bent Sørensen Kjærsgaard is registered as director of TAKEDA PHARMA A/S.
As of May 1, 1998, Jørgen Moestrup has stepped down as adm. dir. of TAKEDA PHARMA A/S.
As of September 1, 1997, Jørgen Moestrup is registered as adm. dir. of TAKEDA PHARMA A/S.
As of September 1, 1997, Jesper Mailind has stepped down as adm. dir. of TAKEDA PHARMA A/S.
On November 15, 1996, the company changed its name from NYCOMED DAK A/S to NYCOMED DANMARK A/S.
As of August 15, 1996, Bjørn Ivar Flatgård has left the board of directors of TAKEDA PHARMA A/S.
As of August 15, 1996, Øyvin Anders Brøymer has left the board of directors of TAKEDA PHARMA A/S.
As of May 14, 1996, Helge Tovborg-Jensen has left the board of directors of TAKEDA PHARMA A/S.
As of June 30, 1995, Jesper Mailind is registered as adm. dir. of TAKEDA PHARMA A/S.
As of June 30, 1995, Anne Bagger Hansen has stepped down as director of TAKEDA PHARMA A/S.
As of May 1, 1995, Helle Kit Knudsen has joined the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Ole Nielsen has joined the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Henrik Kjeldsen has joined the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Gert Juul has left the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Susanne Wollesen has left the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Grethe Inger Suhr has left the board of directors of TAKEDA PHARMA A/S.
As of May 1, 1995, Henrik Kjeldsen has left the board of directors of TAKEDA PHARMA A/S.
As of November 29, 1993, Tore Talseth has left the board of directors of TAKEDA PHARMA A/S.
As of April 29, 1992, Bjørn Jensen has left the board of directors of TAKEDA PHARMA A/S.
On January 24, 1992, the company changed its name from DAK-LABORATORIET A/S to NYCOMED DAK A/S.
As of June 28, 1991, Jørgen Moestrup has left the board of directors of TAKEDA PHARMA A/S.
As of June 28, 1991, Dorte Bøgelund has left the board of directors of TAKEDA PHARMA A/S.
As of February 28, 1991, Ole Tovborg Jensen has left the board of directors of TAKEDA PHARMA A/S.
As of February 28, 1991, Peter John Kielgast has left the board of directors of TAKEDA PHARMA A/S.
As of February 28, 1991, Bodil Kock Strøh has left the board of directors of TAKEDA PHARMA A/S.
As of February 28, 1991, Bent Kersgaard Christiansen Løber has left the board of directors of TAKEDA PHARMA A/S.
As of February 28, 1991, Bent Eichstedt Nielsen has left the board of directors of TAKEDA PHARMA A/S.
As of March 24, 1990, Alejandra Maria Cristina Bonifacini Mørk has left the board of directors of TAKEDA PHARMA A/S.
As of June 30, 1989, Preben Reimer has left the board of directors of TAKEDA PHARMA A/S.
As of June 30, 1989, Anette Larsen has left the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, CJ Partnership I/S has been appointed auditor of TAKEDA PHARMA A/S.
As of January 2, 1984, Jørgen Moestrup has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Helge Tovborg-Jensen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Georg Dedichen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Ole Tovborg Jensen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Peter John Kielgast has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Bodil Kock Strøh has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Preben Reimer has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Bent Kersgaard Christiansen Løber has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Gert Juul has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Bent Eichstedt Nielsen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Carsten Martini Nielsen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Dorte Bøgelund has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Susanne Wollesen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Anette Larsen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Grethe Inger Suhr has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Birthe Gudrun Eriksen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Henrik Kjeldsen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Bjørn Ivar Flatgård has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Øyvin Anders Brøymer has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Bjørn Jensen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Tore Talseth has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Olav Land has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Trond Vegard Jacobsen has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Helge Lund has joined the board of directors of TAKEDA PHARMA A/S.
As of January 2, 1984, Anne Bagger Hansen is registered as director of TAKEDA PHARMA A/S.
TAKEDA PHARMA A/S was founded on January 2, 1984.
Companies in the same industry and area
CVR 27394019
CVR 55541817
CVR 42541877
CVR 45267024
CVR 43401548
companydata.dk